Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Donald · SciRah

Researcher profile · Semantic Scholar

A. Donald

Share profile

A. Donald — researcher profile on SciRah

h-index: 10
Works: 24
Citations: 349

Most-cited papers

Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies.
T. Siler, E. Kerwin, A. Sousa, A. Donald +2 more
2015Respiratory Medicine79 citations Open access
Semantic Scholar
Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials
F. Maltais, Sally J. Singh, A. Donald, G. Crater +3 more
2014Therapeutic Advances in Respiratory Disease73 citations Open access
Semantic Scholar
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial
A. Lazaar, B. Miller, A. Donald, T. Keeley +62 more
2020Respiratory Research67 citations Open access
Semantic Scholar
A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD
T. Siler, A. Donald, D. O'Dell, A. Church +1 more
2016International Journal of COPD26 citations Open access
Semantic Scholar
Efficacy and safety of once-daily GW870086 a novel selective glucocorticoid in mild-moderate asthmatics: a randomised, two-way crossover, controlled clinical trial
P. Bareille, K. Hardes, A. Donald
2013Journal of Asthma15 citations
Semantic Scholar
Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of Inhaled Once-Daily Umeclidinium in Healthy Adults Deficient in CYP2D6 Activity: A Double-Blind, Randomized Clinical Trial
A. Cahn, R. Mehta, A. Preece, James Blowers +1 more
2013Clinical drug investigation15 citations
Semantic Scholar
Safety, tolerability and pharmacokinetics (PK) of repeated doses of GSK573719 inhalation powder, a new long-acting muscarinic antagonist, in healthy adults
R. Mehta, K. Hardes, A. Cahn, A. Newlands +4 more
201115 citations
Semantic Scholar
Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study
J. Riley, C. Kalberg, A. Donald, D. Lipson +2 more
2018ERJ Open Research11 citations Open access
Semantic Scholar
Corrigendum to “Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies” [Respir. Med. 109 (2015) 1155–1163]
T. Siler, E. Kerwin, A. Sousa, A. Donald +2 more
201511 citations Open access
Semantic Scholar
Effects of a combination of vilanterol and umeclidinium on exercise endurance in subjects with COPD: Two randomised clinical trials
F. Maltais, Sally J. Singh, A. Donald, A. Church +3 more
2013European Respiratory Journal10 citations
Semantic Scholar
Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials
J. Riley, M. Tabberer, N. Richard, A. Donald +2 more
2016International Journal of COPD7 citations Open access
Semantic Scholar
a randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 µ g on health-related quality of life in patients with COPD
T. Siler, A. Donald, D. O'Dell, A. Church +1 more
20165 citations
Semantic Scholar
Phase II study of once-daily GSK573719 inhalation powder, a new long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD)
Dennis L. Kelleher, A. Preece, R. Mehta, A. Donald +3 more
2011European Respiratory Journal5 citations
Semantic Scholar
Use of a new dry powder inhaler to deliver umeclidinium/vilanterol in the treatment of COPD
J. Riley, M. Tabberer, N. Richard, A. Donald +2 more
2013European Respiratory Journal4 citations
Semantic Scholar
Efficacy and Safety of Once-Daily Umeclidinium Added to Fluticasone Furoate/Vilanterol in Chronic Obstructive Pulmonary Disease: Results of Two Replicate Randomized 12-Week Studies
T. Siler, E. Kerwin, A. Sousa, A. Donald +2 more
20143 citations
Semantic Scholar
Effect of a Novel Selective Inhaled Steroid on the Allergen-Induced Early and Late Asthmatic Response in Adults with Mild Asthma: A Randomised Study
P. Bareille, A. Allen, K. Hardes, A. Donald
20142 citations
Semantic Scholar
Developing low-carbon salbutamol MDI: assessment of relative bioavailability and pharmacodynamic relative potency of salbutamol MDI with propellant HFA-152a
Sebastian Moreira, Laura Clow, Emily Coles-Piper, A. Donald +6 more
2026BMJ Open Respiratory Research1 citations Open access
Semantic Scholar
A32-12 Developing Low-carbon Salbutamol MDI: Assessment of Safety and Tolerability of Salbutamol With Propellant HFA-152a
A. Weinberg, K. Robbins, D. Slade, L. Clow +11 more
2026American Journal of Respiratory and Critical Care Medicine1 citations
Semantic Scholar
obstructive pulmonary disease : two randomized , double-blind clinical trials Effects of a combination of umeclidinium / vilanterol on exercise endurance in patients with chronic
F. Maltais, Sally J. Singh, A. Donald, G. Crater +3 more
20141 citations
Semantic Scholar
Developing low-carbon metered-dose inhalers: effects of propellant HFA-152a on mucociliary clearance and bronchoconstriction in two Phase 1 randomised trials.
Dave Singh, Italo Poggesi, Stephen Weng, D. Slade +9 more
2026Respiratory Medicine0 citations Open access
Semantic Scholar
A32-42 Patient Insights on Experience With Metered-dose Inhalers Using Novel Low-carbon Propellant HFA-152a Compared With the Current Propellant HFA-134a
R. Tal-Singer, M. Han, A. Kaplan, J. Van +7 more
2026American Journal of Respiratory and Critical Care Medicine0 citations
Semantic Scholar
Cardiovascular events in patients with COPD after long-acting bronchodilator initiation
Dave Singh, Ana R. Sousa, D. Newby, Michele Jonsson Funk +6 more
2026ERJ Open Research0 citations Open access
Semantic Scholar
Disease stability in COPD with umeclidinium/vilanterol (UMEC/VI) compared to tiotropium (TIO), umeclidinium, and salmeterol (SAL): post hoc analyses of ZEP and EMAX studies
Lowie Vanfleteren, M. Dransfield, R. Stacey, Anurita Majumdar +2 more
2025Airway pharmacology and treatment0 citations
Semantic Scholar
P.019: PREREQUISITES FOR CAROTID ULTRASOUND IMAGING STUDIES IN THE IDENTIFICATION AND PREVENTION OF ATHEROSCLEROSIS
E. de Groot, J. Kastelein, A. Donald, J. Deanfield
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Church×10
Invite
A. Church — researcher profile on SciRah
J. Riley×6
Invite
J. Riley — researcher profile on SciRah
T. Siler×5
Invite
T. Siler — researcher profile on SciRah
G. Crater×5
Invite
G. Crater — researcher profile on SciRah

×4

Invite

E. Kerwin — researcher profile on SciRah

Invite

F. Maltais — researcher profile on SciRah

Invite

K. Hardes — researcher profile on SciRah

Invite

D. Slade — researcher profile on SciRah

Invite

A. Sousa — researcher profile on SciRah

Invite

R. Ali — researcher profile on SciRah

Sally J. Singh×3

Invite

Sally J. Singh — researcher profile on SciRah

Invite

A. Goh — researcher profile on SciRah